Bionano Genomics Q4 Sales $6.30M Beat $5.57M Estimate

Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $6.30 million which beat the analyst consensus estimate of $5.57 million by 13.11 percent. This is a 57.89 percent increase over sales of $3.99 million the same

Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $6.30 million which beat the analyst consensus estimate of $5.57 million by 13.11 percent. This is a 57.89 percent increase over sales of $3.99 million the same period last year.

Total
0
Shares
Related Posts
Read More

‘A New Activist Has A Position In Outback Owner Bloomin’ Brands @Rorol Says, Though Analysts Are Unsure Whether It Would Be Any More Successful In Seeking Divestitures Than Other Insurgents Have Previously Been, Except Perhaps In Brazil’ – TheDeal

The Deal on Twitter: "A new #activist has a position in @Outback owner @BloominBrands, @rorol says, though analysts are unsure whether it would be any more successful in seeking divestitures than other insurgents

BLMN